» Authors » Zhuoxian Rong

Zhuoxian Rong

Explore the profile of Zhuoxian Rong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 68
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Z, Guan Y, Gao J, Zhu L, Zeng Z, Jing Q, et al.
Oncogene . 2025 Mar; PMID: 40025229
Tumor cells display profound changes in the metabolism of branched-chain amino acids (BCAA). However, how these changes are regulated to facilitate tumorigenesis is not yet completely understood. Here, we identified...
2.
Zi Y, Liu L, Gao J, Xu X, Guan Y, Rong Z, et al.
EMBO Rep . 2023 Jul; 24(9):e55060. PMID: 37477088
Inflammation plays an important role in the initiation and progression of colorectal cancer (CRC) and leads to β-catenin accumulation in colitis-related CRC. However, the mechanism remains largely unknown. Here, pancreatic...
3.
Rong Z, Zhang L, Li Z, Xiao Z, Duan Y, Ren X, et al.
Oncogene . 2022 Jun; 41(27):3585. PMID: 35701535
No abstract available.
4.
Zi Y, Gao J, Wang C, Guan Y, Li L, Ren X, et al.
Int J Biol Sci . 2022 Mar; 18(4):1539-1554. PMID: 35280671
Hyperactivation of Wnt/β-catenin signaling has been reported in hepatocellular carcinoma (HCC). However, the mechanisms underlying the hyperactivation of Wnt/β-catenin signaling are incompletely understood. In this study, Pantothenate kinase 1 (PANK1)...
5.
Rong Z, Zhang L, Li Z, Xiao Z, Duan Y, Ren X, et al.
Oncogene . 2022 Mar; 41(16):2390-2403. PMID: 35277657
Breast cancer stem cells (BCSCs) are the main drivers of recurrence and metastasis. However, commonly used drugs rarely target BCSCs. Via screenings, we found that Salt-inducible kinase 2 (SIK2) participated...
6.
Wang X, Dou X, Ren X, Rong Z, Sun L, Deng Y, et al.
Front Genet . 2022 Jan; 12:763636. PMID: 35047000
Pancreatic ductal adenocarcinoma (PDAC) is a highly heterogeneous malignancy. Single-cell sequencing (scRNA-seq) technology enables quantitative gene expression measurements that underlie the phenotypic diversity of cells within a tumor. By integrating...
7.
Xie J, Wen M, Zhang J, Wang Z, Wang M, Qiu Y, et al.
Cancer Res . 2022 Jan; 82(5):872-884. PMID: 34987058
Significance: The involvement of the majority of tumor-associated RNA helicases in the DNA damage repair process suggests a new mechanism of tumorigenesis and offers potential alternative therapeutic strategies for cancer.
8.
Qiu Y, Hu W, Wen M, Zhao W, Xie J, Zhang J, et al.
Int J Radiat Oncol Biol Phys . 2021 Dec; 112(5):1229-1242. PMID: 34936928
Purpose: Radioresistance contributes to poor clinical therapeutic efficacy in most cancers. Emerging evidence shows that aberrant DNA damage repair is involved in radioresistance. This study aimed to elucidate the mechanism...
9.
Ren X, Rong Z, Liu X, Gao J, Xu X, Zi Y, et al.
Cancer Res . 2021 Nov; 82(1):60-74. PMID: 34764205
Metabolic reprogramming by oncogenic signaling is a hallmark of cancer. Hyperactivation of Wnt/β-catenin signaling has been reported in hepatocellular carcinoma (HCC). However, the mechanisms inducing hyperactivation of Wnt/β-catenin signaling and...
10.
Ou D, Chen L, He J, Rong Z, Gao J, Li Z, et al.
Cancer Biol Med . 2020 Jun; 17(2):328-342. PMID: 32587772
Improper activation of Wnt/β-catenin signaling has been implicated in human diseases. Beyond the well-studied glycogen synthase kinase 3β (GSK3β) and casein kinase 1 (CK1), other kinases affecting Wnt/β-catenin signaling remain...